Brigit Biofarmaka Technologi (OBAT) Stock Overview
Provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
OBAT Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
PT Brigit Biofarmaka Technologi Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp234.00 |
| 52 Week High | Rp580.00 |
| 52 Week Low | Rp190.00 |
| Beta | 0 |
| 1 Month Change | -22.52% |
| 3 Month Change | -33.90% |
| 1 Year Change | -55.85% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.33% |
Recent News & Updates
Recent updates
Shareholder Returns
| OBAT | ID Personal Products | ID Market | |
|---|---|---|---|
| 7D | 21.2% | 8.4% | 7.3% |
| 1Y | -55.8% | -2.3% | -19.8% |
Return vs Industry: OBAT underperformed the ID Personal Products industry which returned -2.3% over the past year.
Return vs Market: OBAT underperformed the ID Market which returned -19.8% over the past year.
Price Volatility
| OBAT volatility | |
|---|---|
| OBAT Average Weekly Movement | 8.6% |
| Personal Products Industry Average Movement | 5.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in ID Market | 16.5% |
| 10% least volatile stocks in ID Market | 4.4% |
Stable Share Price: OBAT has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: OBAT's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 22 | Is Heriyanto | www.brigit.co.id |
PT Brigit Biofarmaka Technologi Tbk provides manufacturing services for herbal medicine, herbal honey, skincare, cosmetics, botanical tea, and functional powdered drinks in Indonesia. It also offers hair care products, including shampoo, conditioner, hair mask, hair tonic, hair oil, and hair serum and powder, as well as body moisturizer, body cleanser, facial cleanser, moisturizer, essence and serum, face mask, and personal care products. In addition, it provides lip gloss, cushion, foundation, eyeliner, and blush on balm.
PT Brigit Biofarmaka Technologi Tbk Fundamentals Summary
| OBAT fundamental statistics | |
|---|---|
| Market cap | Rp140.40b |
| Earnings (TTM) | Rp22.64b |
| Revenue (TTM) | Rp160.12b |
Is OBAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OBAT income statement (TTM) | |
|---|---|
| Revenue | Rp160.12b |
| Cost of Revenue | Rp98.44b |
| Gross Profit | Rp61.68b |
| Other Expenses | Rp39.04b |
| Earnings | Rp22.64b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.74 |
| Gross Margin | 38.52% |
| Net Profit Margin | 14.14% |
| Debt/Equity Ratio | 6.4% |
How did OBAT perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/13 01:47 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PT Brigit Biofarmaka Technologi Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.